用于炎症的可转化超声分子影像剂的开发
本研究介绍了一种靶向P-选择素的超声分子影像剂TS-07-009的开发、表征及非临床有效性。该制剂在体外对P-选择素具有选择性,在犬短暂心肌缺血模型中再灌注30或90分钟时可见显著超声对比增强,而静息心脏或对照微泡增强可忽略。
要点
- TS-07-009为靶向P-选择素的超声微泡造影剂,体外对P-选择素选择性高于E-选择素。
- 犬短暂心肌缺血再灌注30或90分钟时,TS-07-009在缺血后心肌产生显著超声对比增强。
- 静息心脏或使用对照微泡再灌注90分钟时,增强可忽略。
关键影像表现/征象
- 在动态黏附实验中,造影剂黏附随P-选择素浓度增加而增加。
- 在犬短暂心肌缺血模型中,再灌注30或90分钟时,TS-07-009在缺血后心肌产生显著超声对比增强。
- 在静息(无既往缺血)心脏或再灌注90分钟时使用对照微泡,增强可忽略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This study details the development, characterization and non-clinical efficacy of an ultrasound molecular imaging agent intended for molecular imaging of P-selectin in humans. A targeting ligand based on a recently discovered human selectin ligand was manufactured as fusion protein, and activity for human and mouse P- and E-selectin was evaluated by functional immunoassay. The targeting ligand was covalently conjugated to a lipophilic anchor inserted into a phospholipid microbubble shell. Three lots of the targeted microbubble drug product, TS-07-009, were produced, and assays for size distribution, zeta potential and morphology were established. The suitability of TS-07-009 as a molecular imaging agent was evaluated in vitro in a flow-based adhesion assay and in vivo using a canine model of transient myocardial ischemia. Selectivity for P-selectin over E-selectin was observed in both the human and murine systems. Contrast agent adhesion increased with P-selectin concentration in a dynamic adhesion assay. Significant contrast enhancement was observed on ultrasound imaging with TS-07-009 in post-ischemic canine myocardium at 30 or 90 min of re-perfusion. Negligible enhancement was observed in resting (no prior ischemia) hearts or with a control microbubble 90 min after ischemia. The microbubble contrast agent described here exhibits physiochemical properties and in vivo behavior suitable for development as a clinical imaging agent.
引用
- Luong A, Smith D, Tai CH, et al. Development of a Translatable Ultrasound Molecular Imaging Agent for Inflammation. Ultrasound Med Biol. 2019. PMID: 31899038. doi:10.1016/j.ultrasmedbio.2019.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。